Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 290222

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : August | Volume : 16 | Issue : 8 | Page : QC11 - QC14 Full Version

Adverse Outcomes in Pregnancy with Chronic Hypertension with and without Superimposed Preeclampsia in Urban South Indian Population: A Prospective Observational Study


Published: August 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/55451.16787
Niharika Reddy Kallu, Geeta Kolar, Saritha Redishetty, Pradeep Kumar Reddy Kistampally

1. Junior Resident, Department of Obstetrics and Gynaecology, Fernandez Hospital, Hyderabad, Telangana, India. 2. Foetal Medicine Consultant, Department of Foetal Medicine, Fernandez Hospital, Hyderabad, Telangana, India. 3. Foetal Medicine Consultant, Department of Foetal Medicine, Fernandez Hospital, Hyderabad, Telangana, India. 4. Consultant Medical Oncologist, Department of Medical Oncology, Continental Hospitals, Hyderabad, Telangana, India.

Correspondence Address :
Dr. Niharika Reddy Kallu,
H. No. 9-240, Baharpet, Beside Vignan Junior College, Vikarabad,
Pargi-501501, Telangana, India.
E-mail: knihagalaxy@gmail.com

Abstract

Introduction: Pregnant women with chronic hypertension and who developed superimposed Preeclampsia (PE) had a higher rate of adverse maternal and perinatal outcomes. Prospective data on the outcome of pregnancies with chronic hypertension are sparse.

Aim: To evaluate the maternal and perinatal outcomes in pregnancies complicated by chronic hypertension with and without superimposed PE in South Indian population.

Materials and Methods: A two group, parallel, prospective observational study was carried out in 270 women with singleton pregnancy and chronic hypertension, with and without superimposed PE, also who received antenatal care and delivered in the Department of Obstetrics and Gynaecology at Fernandez Hospital, Hyderabad, Telangana, India from March 2019 to February 2020. A total of 180 women had chronic hypertension without superimposed PE and 90 had superimposed PE (group A, 180 cases; group B, 90 cases). The medical records were reviewed with specific reference to the treatment, development of Foetal Growth Restriction (FGR), maternal and perinatal outcomes. FGR was considered as the primary outcome variable. Secondary variables were stillbirth rate, low birth weight, Neonatal Intensive Care Unit (NICU) admissions, Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) at 5 minutes, gestational age at delivery, caesarean section rate and maternal complications. Categorical variables were assessed by Pearson’s Chi-square test. Continuous variables were assessed by unpaired Student t-test.

Results: The mean maternal age in group A was 32±5 years and in group B was 30±4 years. Adverse maternal outcomes like abruption, Haemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome, and pulmonary oedema were all low in women without superimposed PE than those with superimposed PE (1.6% vs 12.2%, p-value <0.001). There were no maternal deaths in either group. Compared to group A, group B showed higher FGR rate (15.5% vs 51.1%, p-value <0.001), preterm deliveries (<37 weeks) (50.5% vs 80% p-value <0.001), stillbirths (0 vs 13.3%), low APGAR at 5 minutes (1.1% vs 16.6%, p-value <0.001), low birth weight (21.2% vs 71.1%, p-value <0.001), NICU admissions (14.4% vs 43.3%, p-value <0.001). There was no significant difference in the caeserean section rate between the groups (69.4% vs 74.4%, p-value=0.39).

Conclusion: Maternal and perinatal morbidity was higher in women having chronic hypertension with superimposed PE. They need vigilant maternal and foetal surveillance and should be counseled about all the possible adverse outcomes.

Keywords

Abruption, Foetal growth restriction, Preterm delivery, Stillbirth

Chronic hypertension in pregnancy is defined as blood pressure ≥140 mmHg systolic and/or 90 mmHg diastolic before pregnancy or, in recognition that many women seek medical care only once pregnant, before 20 weeks of gestation, use of antihypertensive medications before pregnancy, or persistence of hypertension for >12 weeks after delivery (1). Chronic hypertension presents special challenges to healthcare providers. It is estimated to complicate 3% to 5% of pregnancies (1). Increasing rates of prevalence of chronic hypertension in pregnancy is being observed now-a-days, which may be attributable to increase in maternal age, obesity and the changing lifestyle of women in their reproductive years. Chronic hypertension in pregnancy is associated with many adverse maternal and perinatal outcomes, the most common being the development of superimposed PE (2). About 17% to 25% of pregnant women with chronic hypertension develop superimposed PE (3).

Superimposed Preeclampsia (PE) is defined by the criteria as women with hypertension alone in early gestation, who then develop proteinuria after 20 weeks of gestation or experience a sudden exacerbation of hypertension, or need to escalate the antihypertensive drug dose especially when previously well controlled with these medications, or women with hypertension and proteinuria before 20 weeks of gestation and have sudden manifestation of (1):

- Thrombocytopenia- Platelet count <1 lakh/cc
- Impaired liver function tests- Elevated Liver transaminases to twice the normal concentration.
- New development of renal insufficiency- Serum creatinine >1.1 mg/dL or doubling of serum creatinine in the absence of other renal diseases
- Pulmonary oedema
- Cerebral or visual disturbances
- Symptoms like severe headache, nausea, vomiting, blurring of vision, epigastric pain and oliguria.
- Have sudden, substantial increase in protein excretion.

Maternal adverse outcomes include eclampsia, HELLP syndrome, abruption, pulmonary oedema, disseminated intravascular coagulation, increased rate of induction of labour and caeserean section (4). Perinatal adverse outcomes include increased risk of foetal growth restriction, intrauterine foetal demise, preterm delivery both spontaneous and iatrogenic increased NICU admissions, increased perinatal mortality (5),(6),(7).

These complications are more in chronic hypertensives with superimposed PE than those without. Though there are few studies on adverse outcomes of chronic hypertension in pregnancy, but studies comparing chronic hypertension with and without superimposed PE are less (7),(8). More so, such evidence in the context of Indian population is sparse. Hence, this study was conducted to establish the contemporaneous data, in-depth analysis and evidence-based management of chronic hypertension. It helps in counseling the woman regarding possible adverse events and need for monitoring the mother and foetus.

Material and Methods

A two group, parallel, prospective, observational study was conducted in the Department of Obstetrics and Gynaecology at Fernandez Hospital, Hyderabad, Telangana, India, a tertiary care centre in urban South India from March 2019 to February 2020.Institutional Ethics Committee (Reg.No: ECR/933/inst/TG /2O17) approval was obtained prior to the start of study vide (with reference number 11-2019). Written informed consent was obtained from the subjects.

Sample size calculation: Sample size was calculated by using the sample size calculator for comparative study of percentages allowing an α error of 5% at a power of 80%, with reference values obtained from a similar study Chappell LC et al., (7). A total sample size of 180 was obtained based on proportions of FGR in the study groups with 120 in hypertensive pregnancy without superimposed PE group and 60 in the group with superimposed PE. It was decided to increase the study sample size by 66% to study the outcomes in a larger population.

Inclusion and Exclusion criteria: Pregnant women with singleton pregnancy and chronic hypertension, who attended and received antenatal care at Fernandez Hospital, Hyderabad were included into the study. They were followed-up till their delivery whereas, women with multiple gestation, chromosomally or structurally anomalous babies were excluded from the study.

Study Procedure

Pregnant women, were sequentially recruited and grouped into either of group A or group B based on the absence (group A) or presence (group B) of superimposed PE. The primary outcome variable measured was foetal growth restriction. Secondary variables were stillbirth rate, low birth weight, NICU admissions, APGAR at 5 minutes, gestational age at delivery, caeserean section rate and maternal complications. Preterm delivery and low birth weight were defined as per World Health Organisation (WHO) (9),(10).

Strict definitions of chronic hypertension and superimposed PE as per American College of Obstetrics and Gynaecology (ACOG 2013) was used (1),(11),(12),(13). Lifestyle modification like regular walking, exercises and regular Blood Pressure (BP) monitoring at home was advised (14). Antihypertensives were started in women with blood pressure ≥150/100 mmHg. Women who were already on antihypertensives like beta blockers, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin Receptor Blockers (ARBs) were changed to those safe in pregnancy (labetalol, nifedepin, methyldopa, hydralazine, metaprolol) (15),(16). Investigations like haemogram, urine examination, liver and renal function tests, serum electrolytes, ultrasound abdomen and renal artery doppler, fundoscopy for hypertensive retinopathy screening were done to assess the severity of the disease and evaluation of secondary causes of hypertension (secondary hypertension is the hypertension due to any underlying cause like connective tissue disorders, renal disorder etc.) (1). Findings suggestive of secondary hypertension are: resistant hypertension, hypokalemia (serum potassium level <3 mEq/L), elevated serum creatinine level (>1.1 mg/dL), strong family history of renal disease.

An addition of other antihypertensives were done based on the control of hypertension and with development of PE (17),(18). Women with uncontrolled hypertension even with a multidrug regimen received magnesium sulphate and termination of pregnancy was done if indicated. Their medical records were reviewed and maternal characteristics like age, Body Mass Index (BMI), parity, maternal adverse outcomes i.e., abruption, HELLP syndrome, acute kidney injury, gestational age at delivery and mode of delivery were studied.

Foetal monitoring was done by serial growth scans from 26 weeks, performed by senior foetal medicine consultants in a standardised manner as per International Society of Ultrasound in Obstetrics and Gynaecology (ISUOG) guidelines (19). Diagnosis of FGR, staging, surveillance and timing of delivery were done as per guidelines from the Integrated management of foetal growth restriction by the center for maternal and foetal medicine Barcelona (20). This study is one among those reporting foetal outcomes using the Barcelona protocol.

Perinatal outcomes studied were the development of FGR, stage of FGR, birth weight, stillbirth rate, APGAR at five minutes, NICU admissions.

Statistical Analysis

The FGR was considered as the primary outcome variable. Superimposed PE or without superimposed PE was considered as the primary explanatory variable. Age, BMI and parity were considered as potential confounding variables to all. Continuous variables were summarised as mean and standard deviations, and significance of difference between means of both groups were assessed by unpaired Student t-test. Categorical variables were summarised by frequency and proportions and significance of difference between proportions of both groups were assessed by Chi-square test. A p-value <0.05 was considered statistically significant. IBM Statistical Package for the Social Sciences (SPSS) version 22.0 was used for statistical analysis (21).

Results

The mean maternal age in group A was 32±5 years and in group B was 30±4 years. Maternal age, parity and BMI were comparable between the two groups. Incidence of foetal growth restriction is significantly higher in group B compared to group A (15.5% vs 51.1%, p-value <0.001). The frequency of preterm delivery was higher in group B (50.5% vs 80%, p-value <0.001). NICU admissions (14.4% vs 43.3%, p-value <0.001) and incidence of low birth weight (21.2% vs 71.1%, p-value <0.001) were also higher in group B. There was no significant difference in caesarean section rates (69.4% vs 74.4%, p-value=0.39) between the two groups and there were no maternal deaths observed in both the groups (Table/Fig 1).

Stillbirths were seen only in group B (13.3% i.e. 12/90). Of this six were intrauterine foetal demise due to severe FGR and uncontrolled hypertension. The other six were termination of pregnancy due to abruption, AKI, imminent eclampsia. (Table/Fig 2). These women needed termination of pregnancy within a week of onset of superimposed preeclampsia due to severity of the disease. There were no maternal deaths in either group.

Discussion

Incidence of adverse maternal outcomes like abruption, HELLP syndrome, pulmonary oedema, and AKI were high among those with superimposed PE than those without, supporting the results of other longitudinal studies by Chappell LC et al., (3% vs 0% for HELLP) and Sibai BM et al., (3% vs 1.5% for abruption) (7),(8).

Seely EW, 15 subjects have observed that incidence of foetal growth restriction in chronic hypertensive pregnant women with superimposed PE was double the rates observed in those without superimposed PE, which is like what was observed in the present study wherein, threefold increased incidence was observed in the present study study (15.5% vs 51.1%). Chappell LC et al., reported incidence of low birth weight among the two groups as 21% vs 48%, while our observation in the study population was 21.2% vs 71.1% between group A vs group B (7). The reasons behind such higher incidences of foetal growth restrictions and low birth weight in our study population are not very clear and probably may be attributable to ethnicity, poor hypertension control and maternal nutritional status.Recent studies in Indian population by Verma I et al., in 2021 concluded that FGR in PE group is about 62% vs 17% in chronic hypertension group which is very similar to our study, while another study published in 2020 by Kumar N and Yadav A also reported higher FGR in PE group compared to chronic hypertension (22),(23). However, due to differences in the study design of both these studies compared with the present study and the analysis done to specifically identify the outcomes of different hypertensive disorders of pregnancy rather than comparing outcomes in chronic hypertension in pregnancy with vs without superimposed PE, as in the present study study, makes it inappropriate to draw any comparative conclusions from both these studies.

Preterm births (<37 weeks) were seen in 50.5% of group A and 80% of group B. These figures are markedly higher than those reported in the other studies by Chappell LC et al., (15% and 51% respectively) and Lecarpentier E et al., (20% vs 57%) (7),(24). This difference was possibly due to increased iatrogenic preterm deliveries in view of uncontrolled hypertension. Stillbirths were seen only in group B (13.3%), there were no stillbirths in group A. The stillbirth rate was higher in comparison with other studies like Chappell LC et al., (3%, 4% respectively), Sibai BM et al., (4% and 8%) and Lecarpentier E et al., (4%,4% respectively) (7),(8),(24). One possible explanation for this unexpected result would be difference in the ethnicity. A significantly higher incidence of low APGAR scores at 5 minutes (1.1% vs 16.6%) was observed in the present study while other similar studies have reported no significance (1% vs 2% by Becker DA et al., and 3% vs 10% by Lecarpentier E et al., (24),(25). NICU admissions (14% vs 43%) observed in the present study are similar to those observed in other similar studies like Casagrande L et al., (18% vs 45% for NICU admissions) (26).

Regular maternal supervision and intensive foetal surveillance for superimposed PE is justified for early identification of evolving complications, optimising the treatment, timing of delivery and reducing adverse outcomes. This study provides contemporaneous data, indepth analysis which helps in counseling the woman regarding possible adverse events, need for monitoring the mother and foetus. Multicentric studies including a larger population, not just from a tertiary care centers but including the rural health setups, can provide much more comprehensive information.

Limitation(s)

The present study had a small sample size and hence the validation and extrapolation for larger population becomes a limitation. Hence needs further studies with large data. There might be chances of selection bias as the sample was not randomised, although authors recruited the patients sequentially and allocated to either of the groups based on presence or absence of superimposed PE. As the study was conducted in a tertiary perinatal center, generalisability in a low resource setting would be a challenge in terms of a thorough evaluation, monitoring and management. There can be other confounding factors like low BMI, low socio-economic status that may have their own effects on foetal growth restriction.

Conclusion

The incidence of adverse maternal and perinatal outcomes were more amongst those with superimposed PE than those without. Using Barcelona protocol, the high prevalence of foetal growth restriction, suggesting that heightened surveillance strategies are needed in clinical practice has been highlighted.

References

1.
Committee on Hypertension in Pregnancy. Hypertension in Pregnancy. Washington (DC): American College of Obstetricians and Gynecologists; 2013.
2.
Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ. 2014;348(7):g2301. [crossref] [PubMed]
3.
Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. Am J Obstet Gynecol. 2011;204(4):345.e1-6. [crossref] [PubMed]
4.
ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159-67. [crossref] [PubMed]
5.
Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J, et al. Management of mild chronic hypertension during pregnancy: A review. Obstet Gynecol. 2000;96(5 Pt 2):849-60. [crossref] [PubMed]
6.
Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950-55. [crossref] [PubMed]
7.
Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: A prospective study. Hypertension. 2008;51(4):1002-09. [crossref] [PubMed]
8.
Sibai BM, Lindheimer M, Hauth J, Caritis S, Van Dorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. New England Journal of Medicine. 1998;339(10):667-71. [crossref] [PubMed]
9.
Preterm birth [Internet]. Who.int. 2022 [cited 11 April 2022]. Available from: https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
10.
Low birth weight [Internet]. Who.int. 2022 [cited 11 April 2022]. Available from: https://www.who.int/data/nutrition/nlis/info/low-birth-weight.
11.
Brown MA, Hague WM, Higgins J, Lowe S, Macocoan L, Oates J, et al. The detection, investigation and management of hypertension in pregnancy, full consensus statement of recommendations from the council of the Australasian society for the study of hypertension in pregnancy (ASSHP). Aust NZ J obstet Gynecol. 2000;40:139-56. [crossref] [PubMed]
12.
Von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, et al.; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-27. [crossref] [PubMed]
13.
Wheeler TL 2 nd, Blackhurst DW, Dellinger EH, Ramsey PS. Usage of spot urine protein to creatinine ratios in the evaluation of preeclampsia. Am J Obstet Gynecol. 2007;196(5):465.e1-4. [crossref] [PubMed]
14.
Seely EW, Ecker J. Ellen W seely, Jeffrey Ecker: Chronic hypertension in pregnancy. Circulation AHA. 2014;129(11):1254-61. [crossref] [PubMed]
15.
Friedman JM. ACE inhibitors and congenital anomalies. N Engl J Med. 2006;354(23):2498-500. [crossref] [PubMed]
16.
Moretti ME, Caprara D, Drehuta I, Yeung E, Cheung S, Federico L, et al. The fetal safety of Angiotensin converting enzyme inhibitors and Angiotensin II Receptor Blockers. Obstet Gynecol Int. 2012;2012:658310. [crossref] [PubMed]
17.
Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51(4):960-69. [crossref] [PubMed]
18.
Magee LA, Helewa M, Rey E, von Dadelszen phypertension guideline committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3 Suppl):S1-48. [crossref] [PubMed]
19.
Salomon L, Alfirevic Z, Da Silva Costa F, Deter R, Figueras F, Ghi T, et al. ISUOG Practice Guidelines: Ultrasound assessment of fetal biometry and growth. Ultrasound in Obstetrics & Gynecology. 2019;53(6):715-23. [crossref] [PubMed]
20.
Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86-98. [crossref] [PubMed]
21.
IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.
22.
Verma I, Chugh C, Sood D, Soni R. Perinatal outcome in pregnancies associated with hypertension: A prospective cohort study in a rural tertiary care teaching hospital of North India. Indian Journal of Community Medicine. 2021;46(4):651. [crossref] [PubMed]
23.
Kumar N, Yadav A. Perinatal iutcome in women with hypertensive disorders of pregnancy in rural tertiary center of Northern India: A retrospective cohort Study. Current Pediatric Reviews. 2020;16(1):71-78. [crossref] [PubMed]
24.
Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B, et al. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One. 2013;8(5):e62140. [crossref] [PubMed]
25.
Becker DA, Machemehl HC, Biggio JR, Siegel AM, Tita AT, Harper LM, et al. Pregnancy outcomes of exacerbated chronic hypertension compared with superimposed preeclampsia. Am J Perinatol. 2019;36(8):872-78. [crossref] [PubMed]
26.
Casagrande L, Rezende G, Guida J, Costa R, Parpinelli M, Surita F, et al. Maternal and perinatal outcomes related to superimposed pre-eclampsia in a Brazilian cohort of women with chronic hypertension. International Journal of Gynecology and Obstetrics. 2020;149(2):148-53. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/55451.16787

Date of Submission: Feb 04, 2022
Date of Peer Review: Feb 25, 2022
Date of Acceptance: Jun 20, 2022
Date of Publishing: Aug 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Feb 08, 2022
• Manual Googling: Jun 18, 2022
• iThenticate Software: Jul 25, 2022 (15%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com